Saturday , December 16 2017
Home / Letter From The Editor / SGLT2 Inhibitors Special Editions, February 2014

SGLT2 Inhibitors Special Editions, February 2014

Now that there is a second SGLT-2 inhibitor on the market, prescribers will be approached even more often with information on this new class of drugs. These medications are likely to be big competitors with the DPP-4 inhibitors because they are similarly priced and have almost the same place in oral medication treatment. In this month’s feature, we have a small Homerun Slides presentation looking at the differences between drugs in the two classes and how they affect more than just glucose levels in our patients.